Skip to main content
. Author manuscript; available in PMC: 2022 Apr 19.
Published in final edited form as: Mov Disord. 2021 May 11;36(8):1967–1972. doi: 10.1002/mds.28640

Table 1.

MR analysis between RLS and PD

Inverse variance weighted
MR Egger
Weighted median
Exposure Outcome F R 2 MR-PRESSO b SE P Q test p b SE P Q test p b SE P

RLS PD 217.558 0.035 0.832 −0.003 0.031 0.916 0.780 −0.019 0.064 0.767 0.729 −0.020 0.043 0.632
PD RLS 191.791 0.0315 0.662 −0.012 0.023 0.592 0.300 −0.002 0.050 0.958 0.269 −0.011 0.036 0.749

RLS, restless legs syndrome; PD, Parkinson’s disease; F, “strength” of the genetic instrumental variable; R2, proportion of variance in exposure variable explained by SNPs; MR-PRESSO, Mendelian Randomization Pleiotropy RESidual Sum and Outlier; MR, Mendelian randomization; b, beta; SE, standard error; Q, Cochran’s Q test.